Search Results

61 - 70 of 90 items :

  • "development" x
  • Neurobiology x
Clear All
Bidirectional asymmetry in the neurovisceral communication for the cardiovascular control: New insights

microbiota in hypertension. Curr Opin Nephrol Hypertens 24, 403–409, 2015. Kabouridis PS, Pachnis V. Emerging roles of gut microbiota and the immune system in the development of the enteric nervous system. J Clin Invest 125, 956–964, 2015. Kato T, Ishihara H, Shimizu A, Yokosawa H, Ishii S, Komiya Y. The axonal transport of dipeptidyl aminopeptidase II, angiotensin-converting enzyme and other peptidases in rat sciatic nerves. Neurosci Res 4, 241–248, 1987. Klingelhofer J, Sander D. Cardiovascular consequences of clinical stroke. Baillieres Clin Neurol 6

Open access
Mechanisms involved in the regulation of neuropeptide-mediated neurite outgrowth: a minireview

development. Genes Dev 19, 1-49, 2005. Hall A, Lalli G. Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb Perspect Biol 2, a001818, 2010. Hawes JJ, Narasimhaiah R, Picciotto MR. Galanin and galanin-like peptide modulate neurite outgrowth via protein kinase C-mediated activation of extracellular signal-related kinase. Eur J Neurosci 23, 2937-2946, 2006. He JC, Neves SR, Jordan JD, Iyengar R. Role of the Go/i signaling network in the regulation of neurite outgrowth. Can J Physiol Pharmacol 84, 687

Open access
Sex and salt intake dependent renin-angiotensin plasticity in the liver of the rat

,18–23, 2015. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34, 745–750, 2001. Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Tsujinoue H, Imazu H, Fukui H. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol 20, 1227–1231, 2002. Zhang X, Lassila M, Cooper ME

Open access
Expression of genes encoding IGFBPs, SNARK, CD36, and PECAM1 in the liver of mice treated with chromium disilicide and titanium nitride nanoparticles

. Dejeans N, Barroso K, Fernandez-Zapico ME, Samali A, Chevet E. Novel roles of the unfolded protein response in the control of tumor development and aggressiveness. Semin Cancer Biol 33, 67-73, 2015. Ding M, Bruick RK, Yu Y. Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling. Nat Cell Biol 18, 319-327, 2016. Fu TG, Wang L, Li W, Li JZ, Li J. miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma. Int J Mol Med 37, 1627-1635, 2016. Gokulakrishnan K, Velmurugan K, Ganesan S, Mohan

Open access
Co-exposure to endocrine disruptors: effect of bisphenol A and soy extract on glucose homeostasis and related metabolic disorders in male mice

biomonitoring data sorted by age: Results from a literature review. Int J Hyg Environ Health 220, 282–298, 2017. Chouhan S, Yadav SK, Prakash J, Westfall S, Ghosh A, Agarwal NK, Singh SP. Increase in the expression of inducible nitric oxide synthase on exposure to bisphenol A: a possible cause for decline in steroidogenesis in male mice. Environ Toxicol Pharmacol 39, 405–416, 2015. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 104, 13056

Open access
Hypoxic regulation of the expression of genes encoded estrogen related proteins in U87 glioma cells: eff ect of IRE1 inhibition

, Saltel F, Chevet E. Autocrine control of glioma cells adhesion and migration through IRE1a-mediated cleavage of SPARC mRNA. J Cell Sci 125, 4278-4287, 2012. Dejeans N, Barroso K, Fernandez-Zapico ME, Samali A, Chevet E. Novel roles of the unfolded protein response in the control of tumor development and aggressiveness. Semin Cancer Biol 33, 67-73, 2015. De Luca A, Fiorillo M, Peiris-Pages M, Ozsvari B, Smith DL, Sanchez-Alvarez R, Martinez-Outschoorn UE, Cappello AR, Pezzi V, Lisanti MP, Sotgia F. Mitochondrial biogenesis is required for

Open access
Magnesium upregulates insulin receptor and glucose transporter-4 in streptozotocin-nicotinamide-induced type-2 diabetic rats

. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47, 224- 229, 1998. Masiello P. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int J Biochem Cell Biol 38, 873-893, 2006. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetalogia 28, 412-419, 1985. Mauvais-Jarvis F, Virkamaki A

Open access
Implantation and pregnancy outcome of Sprague-Dawley rats exposed to pirimiphos-methyl

. Desforges M, Sibley C. Placental nutrient supply and fetal development. Int J Dev Biol 54, 377–390, 2010. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T. Wang H. Molecular cues to implantation. Endocr Rev 25, 341–373, 2004. Eskenazi B, Bradman A, Castorina R. Exposure of children to organophosphate pesticides and their potential adverse health effects. Environ Health Perspect l07, 409–419, 1999. Fenster L, Coye MJ. Birthweight of infants born to Hispanic women employed in agriculture. Arch Environ Health 45, 46–52, 1990. Furlong CE, Holland N

Open access
STAT3 and Nrf2 pathways modulate the protective effect of verapamil on lung injury of diabetic rats

N, Peila R, Ding J, Colbert LH, Visser M, Shorr RI, Harris TB. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care 29, 1902-1908, 2006. Godfraind T. Discovery and Development of Calcium Channel Blockers. Front Pharmacol 8, 286, 2017. Hashioka S, Klegeris A, McGeer PL. Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers. Neuropharmacology 63, 685-691, 2012. Heiss EH, Schachner D, Zimmermann K, Dirsch VM. Glucose

Open access
What do we know about sleep paralysis?

paralysis: the Unusual Sleep Experiences Questionnaire (USEQ). CNS Neurosci Ther. 2009;15(3):220-6 40. Fulda S, Hornyak M, Müller K, Cerny L, Beitinger PA, Wetter TC. Development and validation of the Munich Parasomnia Screening (MUPS). Somnologie - Schlafforschung und Schlafmedizin. 2008;12:56-65. 41. Cheyne JA. Situational factors affecting sleep paralysis and associated hallucinations: position and timing effects.J Sleep Res. 2002;11(2):169-77. 42. Stores G. Medication for sleep - wake disorders. Arch Dis Child. 2003;88: 899-903. 43. Hishikawa Y

Open access